UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.781

Sortiert nach

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis

Neurology, 2011-05, Vol.76 (22), p.1858

2011

Link zum Volltext

Verfügbarkeit prüfen

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS

Neurology, 2007-04, Vol.68 (17), p.1390

2007

Link zum Volltext

Verfügbarkeit prüfen

Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2007-03, Vol.68 (13), p.977

2007

Link zum Volltext

Verfügbarkeit prüfen

Teriflunomide added to interferon-β in relapsing multiple sclerosis: a randomized phase II trial

Neurology, 2012-06, Vol.78 (23), p.1877

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks

Multiple sclerosis, 2010-11, Vol.16 (11), p.1385-1392

2010

Link zum Volltext

Verfügbarkeit prüfen

Natalizumab reduces visual loss in patients with relapsing multiple sclerosis

Neurology, 2007-04, Vol.68 (16), p.1299

2007

Link zum Volltext

Verfügbarkeit prüfen

A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses

Neurology, 2006-03, Vol.66 (6), p.894

2006

Link zum Volltext

Verfügbarkeit prüfen

Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion

NeuroImage (Orlando, Fla.), 2007-07, Vol.36 (4), p.1152-1158

2007

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

The New England journal of medicine, 2006-03, Vol.354 (9), p.899-910

2006

Link zum Volltext

Verfügbarkeit prüfen

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

Journal of neurology, 2009-03, Vol.256 (3), p.405-415

2009

Link zum Volltext

Verfügbarkeit prüfen

Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects

Neurology, 2004-06, Vol.62 (11), p.2038

2004

Link zum Volltext

Verfügbarkeit prüfen

Assessing disability progression with the Multiple Sclerosis Functional Composite

Multiple sclerosis, 2009-08, Vol.15 (8), p.984-997

2009

Link zum Volltext

Verfügbarkeit prüfen

Dune activity as a record of late Quaternary aridity in the Northern Kalahari: new evidence from northern Namibia interpreted in the context of regional arid and humid chronologies

Palaeogeography, palaeoclimatology, palaeoecology, 2000-03, Vol.156 (3), p.243-259

2000

Link zum Volltext

Verfügbarkeit prüfen

Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis

The Journal of immunology (1950), 2001-02, Vol.166 (4), p.2831-2841

2001

Link zum Volltext

Verfügbarkeit prüfen

Ventricular enlargement in MS: one-year change at various stages of disease

Neurology, 2006-03, Vol.66 (5), p.693

2006

Link zum Volltext

Verfügbarkeit prüfen

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment

Neurology, 2008-03, Vol.70 (13 Pt 2), p.1134

2008

Link zum Volltext

Verfügbarkeit prüfen

Effects of Inhibitors of the Renin-Angiotensin System on the Efficacy of Interferon beta-1b: A post hoc Analysis of the BEYOND Study

European neurology, 2014-01, Vol.71 (3-4), p.173-179

2014

Link zum Volltext

Verfügbarkeit prüfen

Infusion-related hypersensitivity reactions during natalizumab treatment

Neurology, 2006-11, Vol.67 (9), p.1717

2006

Link zum Volltext

Verfügbarkeit prüfen

PULMONARY ARTERIOVENOUS MALFORMATION: A RARE, TREATABLE CAUSE OF STROKE IN YOUNG ADULTS

International journal of clinical practice (Esher), 2003-10, Vol.57 (8), p.731-733

2003

Link zum Volltext

Verfügbarkeit prüfen

Reducing clinical trial risk in multiple sclerosis

Multiple sclerosis and related disorders, 2016-01, Vol.5, p.81-88

2016

Link zum Volltext

Verfügbarkeit prüfen

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2010-05, Vol.74 (18), p.1463

2010

Link zum Volltext

Verfügbarkeit prüfen

A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis

Multiple sclerosis journal - experimental, translational and clinical, 2015, Vol.1, p.2055217315618687-2055217315618687

2015

Link zum Volltext

Verfügbarkeit prüfen

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2013-06, Vol.381 (9884), p.2167-2175

2013

Link zum Volltext

Verfügbarkeit prüfen

Wind stress forcing of the North Sea ‘pole tide’

Geophysical journal international, 2000-08, Vol.142 (2), p.620-630

2000

Link zum Volltext

Verfügbarkeit prüfen

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet neurology, 2014-10, Vol.13 (10), p.977-986

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.781

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.504)
Mit Volltextzugriff
(2.373)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(2.774)
Japanisch
(311)
Französisch
(2)
Deutsch
(2)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.774)
Life Sciences & Biomedicine
(1.409)
Humans
(1.181)
Male
(710)
Female
(671)
Biological And Medical Sciences
(606)
Medical Sciences
(519)
Middle Aged
(432)
Adult
(424)
Animals
(354)
Aged
(319)
Physical Sciences
(218)
Technology
(196)
Neurosciences & Neurology
(193)
General & Internal Medicine
(168)
Exact Sciences And Technology
(166)
Cardiovascular System & Cardiology
(162)
Adolescent
(157)
Cardiac & Cardiovascular Systems
(144)
Medicine, General & Internal
(141)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS

Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Teriflunomide added to interferon-β in relapsing multiple sclerosis: a randomized phase II trial

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks

Natalizumab reduces visual loss in patients with relapsing multiple sclerosis

A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses

Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects

Assessing disability progression with the Multiple Sclerosis Functional Composite

Dune activity as a record of late Quaternary aridity in the Northern Kalahari: new evidence from northern Namibia interpreted in the context of regional arid and humid chronologies

Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis

Ventricular enlargement in MS: one-year change at various stages of disease

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment

Effects of Inhibitors of the Renin-Angiotensin System on the Efficacy of Interferon beta-1b: A post hoc Analysis of the BEYOND Study

Infusion-related hypersensitivity reactions during natalizumab treatment

PULMONARY ARTERIOVENOUS MALFORMATION: A RARE, TREATABLE CAUSE OF STROKE IN YOUNG ADULTS

Reducing clinical trial risk in multiple sclerosis

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

Wind stress forcing of the North Sea ‘pole tide’

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial

Suchergebnisse filtern